Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.
G7 diplomats are now echoing the Supreme Court of India — why hasn't the Modi govt granted compulsory licences to pharma companies to at least manufacture anti-Covid drugs if not vaccines.
India along with 61 co-sponsors submitted a revised proposal in May on TRIPS waiver for all WTO members regarding prevention, containment, and treatment of Covid.
Vaccine manufacturers China and Russia never came forward to share the formula with or waive IPR for other BRICS members. So much for the cooperation in the Covid fight.
It is time countries acted with a humanitarian approach at WTO and relaxed IPR provisions for Covid-19 vaccines. And it can be done without disincentivising R&D efforts.
Instead of trying to obtain an IP waiver, the govt must enable vaccine manufacturers to expand production & reduce inefficiencies in procurement & distribution.
India and South Africa have proposed a broad waiver from the Trips agreement’s rules on the production and export of vaccines needed to combat the Covid-19 virus.
US, EU, Canada and other developed nations, with access to Covid-19 vaccines, must stop opposing India and South Africa's proposal to waive patent and intellectual property rights.
Forget comparing it with classics like Hrithik’s Ek Pal Ka Jeena or the slick title track of Dhoom 2, Janaab-e-Aali does not even come close to Ghungroo.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS